SUBMISSION OF PAPERS
It is understood that material submitted to the Journal has not been published previously in print or electronic format and is not under consideration by another publication or electronic medium. All manuscripts submitted for publication should be written in clear, plain English (American spelling), and approved by a native English speaker.
Please send three paper copies of the manuscript to the Editor-in-Chief and keep a personal copy for your own reference. The final printout together with a floppy disk and e-mail is to be sent to the Editor’s address after the acceptance of the manuscript.
Those authors who wish to have their photograph(s) published along with their paper(s) are asked to send a glossy photograph (minimum size: width 45 mm, height 60 mm; or up to A4 size, depending on the quality of the photo or a group photo) together with their papers.
All authors must give signed consent for publication in a letter submitted with the manuscript. All manuscripts should be sent to:
Editor-in-Chief
Professor Peter G. Fedor-Freybergh, M.D., Ph.D.,
Mail Box 377, Birger Jarlsgatan 39, S-111 73 Stockholm, Sweden
E-MAIL editor@nel.edu
or to the Deputy Chief-Editor
Professor Michal Karasek, M.D., Ph.D., Dr. h.c.
Laboratory of Electron Microscopy, Chair of Pathomorphology,
Medical University of Lodz, Czechoslowacka 8/10,
92-216 Lodz, POLAND.
TEL/FAX +48 42 675 7613
E-MAIL karasek@psk2.am.lodz.pl
LENGTH OF PAPERS
Unless previously agreed upon with the Editor, papers should not exceed 12 manuscript pages (review papers, 16 pages), including figures, tables and references. A printing charge of US$40.00 per page will be levied when the paper exceeds the limit.
REVIEWING
All submitted manuscripts are reviewed initially by the Editor-in-Chief. Those manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Reviewers are invited external independent scientists who are not members of the editorial staff. Even members of the external independent advisory editorial board may serve as peer-reviewers. The identities of both peer-reviewers and authors are kept confidential. The comments by the reviewers may be conveyed to the authors by the Editor, at his discretion.
Manuscripts are reviewed with due respect for the author’s confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editor. The editor ensures both the authors and the reviewers that the manuscripts sent for review are privileged communications and are the private property of the author.
If an author for any reason wishes to withdraw his/her submitted manuscript from publication, the editor will always respect this wish unless the submitted and accepted manuscript has already passed publishing procedures.
When submitting a manuscript for consideration for publication, authors may suggest the names of potential reviewers of their choice.
The original material of rejected articles will be returned to the authors.
AUTHORITY & RESPONSIBILITY
The intellectual content of the paper is the responsibility of the authors. The Editors and the Publisher accept no responsibility for the opinions and statements of the authors. While every effort will be made by the Editors and the Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequence of inaccurate information. The authors undertake to keep the Editor and the Publisher fully and effectually indemnified against any liability of claims that may arise from the publication of inaccurate and/or misleading data.
COPYRIGHT
It is a condition of publication that the authors transfer the world copyright of their manuscripts to the Neuroendocrinology Letters. All manuscripts should therefore be accompanied by a signed statement that the article is original, is not under consideration or has not been previously published in another journal. Nevertheless, authors will be entitled to publish any part of their paper elsewhere without permission provided the usual acknowledgments are given. Authors will be notified if a request to publish a part or whole of their paper is received. Illustrations, figures, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.
ETHICS
The Editors and the Publisher support the principles of the Declaration of Helsinki of 1975, as revised in 1983, and expect that the authors of papers submitted to the Journal will have obtained ethical consent and followed those legal and regulatory requirements for human experimentation with drugs, including informed consent, according to procedures which apply in their institution and country.
When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on, the care and use of laboratory animals was followed.
PRESENTATION
Manuscripts should be typed double-spaced on numbered pages and conform to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals."
The pages should be numbered consecutively, beginning with the Title page. Each section of the manuscript should commence on a new page, in the following sequence: Title page, Abstract, Key words, Abbreviations, Main text (Introduction, Material and methods, Results and Discussion), Acknowledgments, References, Tables and Figures. Particular attention should be taken to ensure that the manuscript adheres to the Instructions to Authors of the Journal in all respects. The use of footnotes is not permitted.
It is very important that all the text is typed without extra spaces between words and that all text within a paragraph is typed without extra carriage returns between the lines. To make a new paragraph, only a carriage return or together with a tab is allowed. All text should be left aligned (not justified) and without hyphenation (important for peer-review proceedings by fax). For tables, see TABLES.
The Editors reserve the right to alter manuscripts whenever necessary to make them conform to the stylistic and bibliographic conventions of the Journal.
TITLE PAGE
Page 1 of the manuscript should contain:
1. The title itself.
2. The name(s) of the author(s), first name(s) spelled out, family name underlined and highest academic degree.
3. The name(s) of the department(s) or institution(s) from which the study originated.
4. The name and full address, including telephone and fax numbers, e-mail address(es) and other useful information of the corresponding author.The authors are obliged to inform the publisher immediately about any change of their fax, telephone, e-mail and ordinary mail address by e-mail: info@nel.edu or by fax: +46 8 6640771.
5. A "running headline," a maximum of 40 characters, including word spaces.
ABSTRACT & KEY WORDS
Page 2 of the manuscript should carry both the title and an abstract, together with the key words. A structured abstract not exceeding 250 words should state what was done, including objectives, design, setting, results, the main findings, conclusions, and how the work was interpreted. Additional headings may be used. Each heading should begin a new paragraph.
The abstract should be followed by 5 to 10 key words. The key words should be separated by semicolons. The key words will be included in the Subject Index of the volume.
ABBREVIATIONS & UNITS
On page 3 of the manuscript, list abbreviations and symbols used and spell them out in full. Abbreviations and symbols must be standard, and SI units (The International System of Units) should be used throughout. Drugs should be described by their official names, but trade names should be indicated in brackets the first time a drug is quoted in the main text.
MAIN TEXT
The text is conventionally divided into sections headed: Introduction, Material and methods, Results and Discussion. Lengthy papers may require subheadings for clarification.
INTRODUCTION
State clearly the purpose of the paper. Do not review the subject extensively and give only pertinent references.
MATERIAL & METHODS
Describe your selection of the observational subjects (patients or laboratory animals, including controls) clearly. Describe the study population in detail. Identify the methods and procedures in sufficient detail to allow other workers to reproduce the results. If the methods used are new or substantially modified, describe them and state their limitations.
When reporting research on human beings, the authors must include an assurance that the work was approved by a medical ethics committee and that the subjects gave their informed consent to participate. (See Ethics.)
RESULTS
Do not repeat in the text all the data displayed in the tables or illustrations; only important observations should be emphasized or summarized.
DISCUSSION
Emphasize only the new and important aspects and conclusions of the study, including the implications and the limitations of the findings and their relation to other relevant studies. The conclusions should be clearly linked with the objectives of the study. Avoid unqualified statements and conclusions that are not supported by the data. Do not claim priority, and do not allude to work in progress. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.
STATISTICS
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported details. The design of the study and the data sources should be clearly identified. The statistical methods used should be described so that it is clear which method was used and where. Give relevant references and additional details if nonstandard methods or analyses have been applied. The basic principle is to supply sufficient information about design and analysis to allow the research to be repeated by someone else. The presentation of the analysis should include relevant summaries of the data, not just the results of significance testing. The use of confidence interval is encouraged.
REFERENCES
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in the text, tables, figures and legends by Arabic numerals in brackets e.g. [1, 5].
References within the tables, figures or legends should be numbered in accordance with the order in which they appear in the text. Only papers published or in press should be numbered and included in the reference list.
Use the form of references adopted by the Index Medicus, i.e. the Vancouver Style (see Br Med J 1997; 314:66?, or N Engl J Med 1991; 324:424?, JAMA 1997; 277:927?4).
Similarly, the titles of journals should be abbreviated according to the style used in the Index Medicus.
Examples of the correct form of references:
1. Standard journal article
List all authors when six or less. When seven or more, list only the first six and add et al.
Example: Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer 1996; 73:1006?2.
If the language is not English, add the translated title in brackets, e.g. Swedin G. Transkutan elektrisk nervstimulering som smärtlindring vid förlossning. [(Transcutaneous electrical nerve stimulation for analgesia in childbirth.) (In Swedish with English abstract.)] Läkartidningen 1979; 776:1946?.
2. Books and other monographs
a/ Personal author(s):
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
b/ Editor(s) as author(s):
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
c/ Chapter in a book:
Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh J Brenner BM, editors. Hypertension: pathophysiology, diagnosis, management. 2nd ed. New York: Raven Press; 1995. p. 465?8.
d/ Conference proceedings:
Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceed ings of the 10th International Congress of EM and Clinical Neurophysiology; Oct 15?9, 1995; Kyoto, Japan. Amsterdam: Elsevier; 1996.
e/ Conference paper:
Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in med ical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; Sept 6?0, 1992; Geneva, Switzerland. Amsterdam: North-Holland; 1992. p. 1561?.
f/ Dissertation:
Kaplan SJ. Post-hospital home health care: the elderly’s access and utilization (dissertation). St. Louis (MO): Washington Univ.; 1995.
TABLES
Tables should be typed on separate sheets. They should be numbered consecutively in Roman numerals and provided with a concise title. Vertical and horizontal lines should not be used within the body of the table. Be sure that each table is cited in the text.
FIGURES (Figures, illustrations, graphs, etc.)
All illustrations should be numbered consecutively in Arabic numerals as figures whether they are figures, photographs, representational drawings or graphs. Legends for figures should be collected together and presented on a separate manuscript page.
All figures (figures, illustrations, photographs, representational drawings, graphs, etc.) must be professionally executed; freehand or typewritten lettering is unacceptable.
All figures should be specifically referred to in the text, e.g. Figure 3.
Figures can be sent as:
a/ PC compatible Adobe Illustrator 8.0 .ai, 6.0x .ai files or .eps files (.eps obligatory for Mac users) with fonts included with the file (not converted to vector/outline illustration); at the same time the original program used for illustrations (figures) should also be attached (even original Mac files); as well as .pdf files if possible. Other files as .tif or .eps files are accepted if the resolution 300 dpi for minimum original size is provided. Files can be compressed with win-zip;
b/ Excel files accepted (PC compatible) as separate files on disk for final manuscripts (all legends to these figures should be included at the end of the main document file - see manuscripts on disks);
c/ original computer prints; or as
d/ glossy prints or photographs, depending on the quality required by the author.
Any lettering or annotation on figures should be indicated on a tracing overlay or on a copy of the original. The use of symbols in illustrations should be consistent with usage within the paper. All figures should be identified on the back by the name of the principal author and the figure number. If the orientation of an illustration is not obvious, it should be indicated on the back.
All exceptions to the above should be agreed upon after contact with our Art Director (art.director@nel.edu) or Publisher (publisher@nel.edu).
ACKNOWLEDGMENTS (separate sheet)
The scientific and material contributions of others to the work should be acknowledged. Any grant supports should be listed and permission for reproduction of published material acknowledged. Authors are responsible for obtaining written permission from anyone acknowledged by name. The acknowledgments will be published as an appendix to the text.
MANUSCRIPTS ON DISKS
When papers have been accepted for publication and after any revision has been completed, authors should supply a full copy of the accepted manuscript on a floppy disk (and by e-mail as well to ms@nel.edu). The final printed version and that on the diskette must be identical.
Be certain to include a printout of the version of the article that is on the disk. Put only the final version of the manuscript on the disk. Every diskette must be clearly labeled with name of the journal, author and title, file content, format, software and program version number. Authors are advised always to keep a copy of the disk, as no responsibility can be accepted for loss.
Files accepted are:
1. PC compatible .rtf files (obligatory) and Word.doc files
2. Text files (.txt)
3. For illustrations—see FIGURES
4. All exceptions to the above should be agreed upon after contact with our Art Director (art.director@nel.edu) or Publisher (publisher@nel.edu).
PROOFS
Before publication the designated author will receive a copy of the final version of the paper, which should be read carefully for errors and returned promptly. Proofs will be sent for the correction of typographic errors only. No change in makeup can be accepted. Proofs not returned within 7 days will be considered approved by the author(s).
DOCTORAL THESES & DISSERTATIONS in brief
This Journal encourages the submission of important works by young investigators, researchers and practitioners. In this section the Editor wishes to recognize innovative research conducted during graduate and postgraduate studies. Each doctoral thesis or dissertation should contain an abstract and provide a concise synopsis (10 manuscript pages maximum) of the major findings presented in the final version.
CASE REPORTS & SHORT REPORTS
Case reports and short reports do not require an abstract. They should not exceed 800 words and generally not contain more than seven references and two tables and/or two figures.
LETTERS TO THE EDITOR
The Neuroendocrinology Letters has a section carrying comments, questions, or criticism about articles that have been published and where the original authors can respond. This section takes the form of Letters to the Editor, where also other topics and views from readers may be published and discussed.
SUPPLEMENTS
Monographs or series of articles that have undergone conventional scientific review, university approved theses, conference proceedings, symposia on related issues or topics, etc. may be printed as supplements to the Neuroendocrinology Letters. Supplements are published as a separate issue of the Journal. They will be published subject to editorial approval regarding the relevance of their content to the scope of the Journal.
FREE COPIES
Until further notice authors will get two free copies of the Journal.
REPRINTS
No reprints are supplied free of charge. Authors can only order a minimum 100 reprints of their contribution at the time of acceptance.
Prices are as follows:
1? pages US$155.00; 9?6 pages US$210.00
Payment for reprints is to be made payable to Society of Integrated Sciences.
Please contact publisher@nel.edu
a/ by bank transfer to UNIBANK A/S, Copenhagen, Account No. 5005 851 417 (SWIFT code UNIBDKKK); or to Unibank A/S
b/ by check or by Visa/MasterCard payable to Society of Integrated Sciences.
Please contact publisher@nel.edu
and order copy/check sent by ordinary mail to:
Neuroendocrinology Letters, Mail Box 377, Birger Jarlsgatan 39,
S-111 73 Stockholm, Sweden.
The order form can be sent by request on fax: +46 8 664 0771 or e-mail: info@nel.edu
ADDITIONAL CONTACT INFORMATION
If you have any additional questions, please do not hesitate to contact us.
E-mail:
Correspondence and information: info@nel.edu
Correspondence to the Editor-in-Chief: editor@nel.edu
Correspondence to the Art & PR Director: art.director@nel.edu
Publisher contact:
Information to our Publisher: publisher@nel.edu
Information about subscriptions: publisher@nel.edu
Advertisement proposal to: art.director@nel.edu
Information to the Prenatal Journal: prenatal.international@nel.edu
Example of a Structured Abstract in NEL
OBJECTIVES: The distribution of serotonin (5-HT) and its effect on insulin and glucagon secretion were investigated to examine whether there are changes in the pattern of distribution and effect of 5-HT after the onset of experimental diabetes.
METHODS: The pattern of 5-HT and its effect of insulin and glucagon secretion was examined using immunohistochemical and radioimmunoassay techniques, respectively.
RESULTS: 5-HT was demonstrated mainly in the neural elements of the pancreas. 5-HT-containing fine varicose nerve fibers were discerned in the wall of blood vessels and pancreatic ducts.
5-HT-containing nerves were also observed in the periacinar and periinsular regions of normal pancreas. The pattern or intensity of the distribution of serotonergic nerves did not change after the onset of diabetes. The perivascular, periductal, periacinar and periinsular regions of diabetic pancreas all contained 5-HT positive nerves. 5-HT elicited marked increases in insulin secretion from normal pancreas but had an inhibitory effect on insulin secretion from diabetic pancreatic tissues. In contrast, 5-HT inhibited glucagon secretion from normal pancreatic tissue fragments but stimulated glucagon release from diabetic pancreatic tissue fragments.
CONCLUSION: 5-HT is well distributed in normal and diabetic pancreatic tissues and has stimulatory effects on insulin secretion from normal pancreas and glucagon secretion from diabetic pancreas. This result indicates that although 5-HT may help in the maintenance of the blood sugar level in normal pancreas by increasing insulin secretion and decreasing glucagon secretion, it may also aggravate the hyperglycemia observed in diabetes mellitus and hence exacerbate the symptoms of hyperglycemia in poorly controlled diabetes mellitus.
Example of References in NEL
1 Adeghate E, Donáth T. Intramural serotonin immunoreactive cells in normal and transplanted pancreas. Biogenic Amines 1990; 7:385-390.
2 Cardinali DP, Larin F, Wurtman RJ. Control of the rat pineal gland by light spectra. Proc Natl Acad Sci USA 1972; 69:2003-2005.
3 Nishino T, Kodaira T, Shina S, Imagawa K, Shima K, Kumahara Y, et al. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragments. Clin Chem 1981; 27:1690-1697.
4 Hellerstrom C, Swenne I, Andersson A. Islet cell replication and diabetes. In: Lefebvre PJ, Pipeleers DG, editors. The pathology of the endocrine pancreas in diabetes. Berlin: Springer-Verlag; 1988.
5 Pathak MA, Nghiem P, Fitzpatrick TB. Acute and chronic effects of the sun. In: Freedberg IM, Eisen AZ, Wolff K, Austen LA, Goldsmith K, Katz SI, Fritzpatrick TB, editors. Fitzpatrick’s Dermatology in General Medicine, 5th edition. New York: McGraw-Hill; 1999. p. 1598-1607.
6 Karasek M. Zaleznosc ultrastruktury szyszynki szczura od wieku. [(The dependence of white rat pineal gland ultrastructure on age.) (In Polish with English abstract)] Endokrynol Pol 1974; 25:275-287.